Subclavian or Transaortic TAVR Implant
Device
Abbott Laboratories
Total Payments
$87,568
Transactions
9
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $87,568 | 9 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $87,568 | 9 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Assessment of the St Jude Medical Portico Resheathable Aortic Valve System - Alternative Access | Abbott Laboratories | $87,568 | 0 |
Top Doctors Receiving Payments for Subclavian or Transaortic TAVR Implant
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $87,568 | 9 |
Ad
Manufacturing Companies
- Abbott Laboratories $87,568
Product Information
- Type Device
- Total Payments $87,568
- Total Doctors 0
- Transactions 9
About Subclavian or Transaortic TAVR Implant
Subclavian or Transaortic TAVR Implant is a device associated with $87,568 in payments to 0 healthcare providers, recorded across 9 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2018 to 2018. In 2018, $87,568 was paid across 9 transactions to 0 doctors.
The most common payment nature for Subclavian or Transaortic TAVR Implant is "Unspecified" ($87,568, 100.0% of total).
Subclavian or Transaortic TAVR Implant is associated with 1 research study, including "Assessment of the St Jude Medical Portico Resheathable Aortic Valve System - Alternative Access" ($87,568).